Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan
· Delayed Price · Currency is TWD 51.20
-4.20 (-7.58%)
Apr 9, 2025, 1:30 PM CST
Easywell Biomedicals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 325.67 | 262.91 | 159.03 | 153.03 | 144.89 | Upgrade
|
Short-Term Investments | 120.27 | 85.12 | 180.51 | 271.24 | 85.7 | Upgrade
|
Trading Asset Securities | 20.16 | - | - | 15.01 | - | Upgrade
|
Cash & Short-Term Investments | 466.1 | 348.03 | 339.54 | 439.28 | 230.59 | Upgrade
|
Cash Growth | 33.92% | 2.50% | -22.71% | 90.50% | -2.81% | Upgrade
|
Accounts Receivable | 42.45 | 66.93 | 20.48 | 30.58 | 25.69 | Upgrade
|
Other Receivables | 15.51 | 1.38 | 3.52 | 3.23 | 0.88 | Upgrade
|
Receivables | 57.96 | 68.31 | 23.99 | 33.82 | 26.57 | Upgrade
|
Inventory | 259.26 | 42.17 | 26.83 | 20.55 | 31.26 | Upgrade
|
Prepaid Expenses | 34.88 | 49.12 | 22.09 | 16.45 | 14.5 | Upgrade
|
Total Current Assets | 818.2 | 507.64 | 412.44 | 510.09 | 302.92 | Upgrade
|
Property, Plant & Equipment | 545.49 | 542.2 | 572.71 | 555.54 | 583.7 | Upgrade
|
Long-Term Investments | 0.06 | 0.06 | 0.06 | - | 11.24 | Upgrade
|
Other Intangible Assets | 136.52 | 156.1 | 168.44 | 179.84 | 139.99 | Upgrade
|
Other Long-Term Assets | 5.04 | 7.8 | 19.5 | 18.44 | 69.86 | Upgrade
|
Total Assets | 1,505 | 1,214 | 1,173 | 1,264 | 1,108 | Upgrade
|
Accounts Payable | 45.63 | 9.42 | 2.36 | 0.47 | 0.4 | Upgrade
|
Short-Term Debt | 201.09 | 43.27 | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 10.2 | Upgrade
|
Current Portion of Leases | 20.73 | 12.63 | 11.47 | 9.86 | 9.76 | Upgrade
|
Current Unearned Revenue | 33.74 | 39.8 | 34.19 | 11.75 | 16.23 | Upgrade
|
Other Current Liabilities | 122.51 | 22.45 | 16.1 | 14.11 | 11.51 | Upgrade
|
Total Current Liabilities | 423.71 | 127.57 | 64.11 | 36.18 | 48.09 | Upgrade
|
Long-Term Debt | - | - | - | - | 7.1 | Upgrade
|
Long-Term Leases | 342.46 | 330.45 | 338.48 | 315.64 | 288.89 | Upgrade
|
Other Long-Term Liabilities | - | 131.97 | - | - | 0.11 | Upgrade
|
Total Liabilities | 766.17 | 589.99 | 402.6 | 351.82 | 344.2 | Upgrade
|
Common Stock | 1,218 | 1,159 | 1,144 | 1,634 | 1,394 | Upgrade
|
Additional Paid-In Capital | 132.98 | 35.4 | 1.11 | 90.87 | 77.05 | Upgrade
|
Retained Earnings | -654.35 | -570.16 | -422.31 | -841.21 | -766.76 | Upgrade
|
Comprehensive Income & Other | 22.07 | -11.09 | 16.01 | -9.8 | -0.1 | Upgrade
|
Total Common Equity | 718.61 | 612.81 | 738.46 | 873.66 | 703.99 | Upgrade
|
Minority Interest | 20.53 | 10.98 | 32.1 | 38.44 | 59.53 | Upgrade
|
Shareholders' Equity | 739.14 | 623.8 | 770.56 | 912.09 | 763.52 | Upgrade
|
Total Liabilities & Equity | 1,505 | 1,214 | 1,173 | 1,264 | 1,108 | Upgrade
|
Total Debt | 564.28 | 386.34 | 349.96 | 325.5 | 315.94 | Upgrade
|
Net Cash (Debt) | -98.19 | -38.31 | -10.42 | 113.78 | -85.35 | Upgrade
|
Net Cash Per Share | -0.82 | -0.33 | -0.09 | 1.07 | -0.92 | Upgrade
|
Filing Date Shares Outstanding | 121.79 | 115.87 | 114.37 | 114.37 | 97.57 | Upgrade
|
Total Common Shares Outstanding | 121.79 | 115.87 | 114.37 | 114.37 | 97.57 | Upgrade
|
Working Capital | 394.49 | 380.07 | 348.33 | 473.91 | 254.83 | Upgrade
|
Book Value Per Share | 5.90 | 5.29 | 6.46 | 7.64 | 7.22 | Upgrade
|
Tangible Book Value | 582.09 | 456.72 | 570.02 | 693.81 | 564 | Upgrade
|
Tangible Book Value Per Share | 4.78 | 3.94 | 4.98 | 6.07 | 5.78 | Upgrade
|
Machinery | 535.61 | 487.94 | 481.86 | 462.27 | 521.83 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.